GB9125891D0 - Antiviral agent - Google Patents

Antiviral agent

Info

Publication number
GB9125891D0
GB9125891D0 GB919125891A GB9125891A GB9125891D0 GB 9125891 D0 GB9125891 D0 GB 9125891D0 GB 919125891 A GB919125891 A GB 919125891A GB 9125891 A GB9125891 A GB 9125891A GB 9125891 D0 GB9125891 D0 GB 9125891D0
Authority
GB
United Kingdom
Prior art keywords
antiviral agent
antiviral
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919125891A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Cancer Research
Original Assignee
Institute of Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Cancer Research filed Critical Institute of Cancer Research
Priority to GB919125891A priority Critical patent/GB9125891D0/en
Publication of GB9125891D0 publication Critical patent/GB9125891D0/en
Priority to PCT/GB1992/002256 priority patent/WO1993011267A1/en
Priority to AU30898/92A priority patent/AU3089892A/en
Pending legal-status Critical Current

Links

GB919125891A 1991-12-05 1991-12-05 Antiviral agent Pending GB9125891D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB919125891A GB9125891D0 (en) 1991-12-05 1991-12-05 Antiviral agent
PCT/GB1992/002256 WO1993011267A1 (en) 1991-12-05 1992-12-04 Antiviral agent comprising antisense oligonucleotides complementary to the bhrf1 gene of epstein-barr virus
AU30898/92A AU3089892A (en) 1991-12-05 1992-12-04 Antiviral agent comprising antisense oligonucleotides complementary to the bhrf1 gene of epstein-barr virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919125891A GB9125891D0 (en) 1991-12-05 1991-12-05 Antiviral agent

Publications (1)

Publication Number Publication Date
GB9125891D0 true GB9125891D0 (en) 1992-02-05

Family

ID=10705764

Family Applications (1)

Application Number Title Priority Date Filing Date
GB919125891A Pending GB9125891D0 (en) 1991-12-05 1991-12-05 Antiviral agent

Country Status (3)

Country Link
AU (1) AU3089892A (en)
GB (1) GB9125891D0 (en)
WO (1) WO1993011267A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0779704B2 (en) * 1990-08-16 1995-08-30 アイシス・ファーマシューティカルス・インコーポレーテッド Candida suppression
US5550047A (en) * 1994-02-18 1996-08-27 University Of Massachusetts Oligonucleotides with anti-Epstein-Barr virus activity
US5837854A (en) * 1996-04-05 1998-11-17 University Of Massachusetts Oligonucleotides with anti-Epstein-Barr virus activity
US6441135B1 (en) 1997-03-20 2002-08-27 Tanox, Inc. Bak binding protein, DNA encoding the protein, and methods of use thereof
US6043055A (en) 1997-11-07 2000-03-28 The Board Of Trustees Of The Leland Stanford Junior University Mammalian pro-apoptotic Bok genes and their uses
EP1060271B1 (en) 1998-03-04 2009-04-22 bioMerieux B.V. Amplification and detection of ebv-barf1 expression for diagnosis of nasopharyngeal carcinoma

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5248670A (en) * 1990-02-26 1993-09-28 Isis Pharmaceuticals, Inc. Antisense oligonucleotides for inhibiting herpesviruses
AU8872191A (en) * 1990-09-21 1992-04-15 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Method of inhibiting viral production

Also Published As

Publication number Publication date
WO1993011267A1 (en) 1993-06-10
AU3089892A (en) 1993-06-28

Similar Documents

Publication Publication Date Title
CS114591A3 (en) Antiviral mixtures
GB2269526B (en) Fire-protecting suit
ZA913721B (en) Antiviral agents
PH27609A (en) Antiviral agents
EP0494850A3 (en) Novel antiviral compounds
GB9218906D0 (en) Bioimmunoassay
EP0497988A4 (en) Antiviral agent
GB9125891D0 (en) Antiviral agent
EP0450065A4 (en) Antiviral agent
EP0583161A3 (en) 4-aminopyrrole-2-carboxamide derivatives as antiviral agents
GB9116030D0 (en) Antiviral compositions
AU1699992A (en) Dibenzothiazepinthione as antiviral agents
ZA923544B (en) Antiviral compounds
GB9122073D0 (en) Antiviral agents
GB9215176D0 (en) Antiviral combinations
GB9214409D0 (en) Antiviral agents
GB9123873D0 (en) Antiviral compounds
HRP930455B1 (en) Antiviral compounds
IE901311L (en) Antiviral compounds
GB9214408D0 (en) Antiviral compounds
AU373P (en) PLUMWHITE Chamelaucium uncinatum x micranthum
AU374P (en) EARLYBIRD Chamelaucium uncinatum x micranthum
AU376P (en) MOONSTAR Chamelaucium uncinatum x micranthum
AU448P (en) WHITEFIRE Chamelaucium uncinatum x forestii
AU372P (en) MOONSTRUCK Chamelaucium uncinatum x micranthum